1YRSGuangzhou K.y Biotechnology Co., Ltd.

FIRMENÜBERSICHT

Firmenalbum

Grundlegende Informationen
Guangzhou K.Y Biotechnology Co.LTD is a comprehensive enterprise integrating development, design, manufacturing and sales. The factory covers an area of more than 20, 000 square meters and has passed FDA, GMP, ISO22716, SA8000, TUV and SEDEX social responsibility audits. The factory has 40 fully automatic production lines and more than 200 employees. At present, a fully automatic cosmetics factory planned and designed by experts from the 20-mu design institute is under construction. The company has a reasonable talent structure. It has a number of rigorous thinking and 20 years of rich experience in R& D and technology. We adhere to the management principle of "quality first, service first, continuous improvement, innovation to satisfy customers", and "zero defect, zero complaint" as the quality goal. We are committed to advocating natural aesthetics, producing pure natural, additive-free skin care products and make-up. We have won a reputation for the uniqueness of product formulas, and have established a mature global sales network in Europe and the United States, Southeast Asia, the Middle East and Africa.
4.7/5
Zufrieden
47 Reviews
  • Transaktionen
    -
  • Reaktionszeit
    ≤2h
  • Reaktionsrate
    99.76%
Unternehmenstyp
Hersteller, Handelsgesellschaft
Land/Region
Guangdong, China
HauptprodukteGesamtzahl der Beschäftigten
-
Gesamtjahresumsatz
US$2.5 Million - US$5 Million
Gründungsjahr
2015
Zertifizierungen
-
Produkt-Zertifizierungen
-
Patente
-
Marken
-
Hauptmärkte

PRODUKTKAPAZITÄT

Fabrikinformationen

Fabrikgröße
5,000-10,000 square meters
Land/Region der Fabrik
4th Floor, Building A, No. 29, Shuanghe Second Road, Shuanghe Industrial Zone, Changhong Village, Jiahe Street, Baiyun District, Guangzhou City
Anzahl der Produktionslinien
10
Auftragsproduktion
OEM Service Offered, Design Service Offered, Buyer Label Offered
Jährlicher Produktionswert
US$5 Million - US$10 Million

F&E-KOMPETENZEN

Forschung und Entwicklung

21 - 30 People